← Browse by Condition
Medical Condition

proptosis

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2, Phase 3
NCT06112340 Phase 2, Phase 3
Recruiting

Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

Enrollment
75 pts
Location
United States
Sponsor
Sling Therapeutics, Inc.
View Trial →